miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241713268 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Francesca Salvatori und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: MicroRNAs, Myocardial Infarction. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 253 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Ferrara.
Abstract (Originalsprache)
Myocardial infarction (MI) is one of the leading causes of death in Western countries. An early diagnosis decreases subsequent severe complications such as wall remodeling or heart failure and improves treatments and interventions. Novel therapeutic targets have been recognized and, together with the development of direct and indirect epidrugs, the role of non-coding RNAs (ncRNAs) yields great expectancy. ncRNAs are a group of RNAs not translated into a product and, among them, microRNAs (miRNAs) are the most investigated subgroup since they are involved in several pathological processes related to MI and post-MI phases such as inflammation, apoptosis, angiogenesis, and fibrosis. These processes and pathways are finely tuned by miRNAs via complex mechanisms. We are at the beginning of the investigation and the main paths are still underexplored. In this review, we provide a comprehensive discussion of the recent findings on epigenetic changes involved in the first phases after MI as well as on the role of the several miRNAs. We focused on miRNAs function and on their relationship with key molecules and cells involved in healing processes after an ischemic accident, while also giving insight into the discrepancy between males and females in the prognosis of cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
- Centre Haemostasis & Thrombosis, University of Ferrara, 44121 Ferrara, Italy.
- Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), 10589 Berlin, Germany.
- Department of Environmental Science and Prevention, University of Ferrara, 44121 Ferrara, Italy.
- LTTA Centre, University of Ferrara, 44121 Ferrara, Italy.
- University Centre for Studies on Gender Medicine, University of Ferrara, 44121 Ferrara, Italy.
ORCID-Profile: Francesca Salvatori, Ajay Vikram Singh, Veronica Tisato, Donato Gemmati
Förderung
- University of Ferrara
Zitieren
APA
Salvatori, F., D'Aversa, E., Serino, M. L., Singh, A. V., Secchiero, P., Zauli, G., Tisato, V., & Gemmati, D. (2023). miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241713268
Vancouver
Salvatori F, D'Aversa E, Serino ML, Singh AV, Secchiero P, Zauli G, et al. miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241713268
BibTeX
@article{Salvatori2023,
author = {Salvatori, Francesca and D'Aversa, Elisabetta and Serino, Maria Luisa and Singh, Ajay Vikram and Secchiero, Paola and Zauli, Giorgio and Tisato, Veronica and Gemmati, Donato},
title = {miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241713268}
}
EUVIMED